Intraperitoneal Treatment of Cambinol, a Synthetic SIRT1 and SIRT2 Inhibitory Compound, Exacerbates Brucella abortus 544 Burden in the Spleens of Institute of Cancer Research Mice
2024

Cambinol Treatment Increases Brucella Burden in Mice

Sample size: 6 publication Evidence: moderate

Author Information

Author(s): Reyes Alisha Wehdnesday Bernardo, Huy Tran Xuan Ngoc, Nguyen Trang Thi, Salad Said Abdi, Aguilar Ched Nicole Turbela, Min Wongi, Lee Hu Jang, Kim Suk

Primary Institution: University of the Philippines Los BaƱos

Hypothesis

Does cambinol treatment affect the progression of Brucella abortus infection in mice?

Conclusion

Cambinol treatment exacerbated the splenic proliferation of Brucella in mice and reduced anti-inflammatory cytokine IL-10 levels.

Supporting Evidence

  • Cambinol treatment did not affect the viability of RAW264.7 cells.
  • Brucella colony-forming units were significantly higher in the spleens of treated mice.
  • IL-10 serum levels were lower in treated mice at 7 days post-infection.

Takeaway

Researchers found that a drug called cambinol made it easier for a bacteria called Brucella to grow in mice, which is not good for their health.

Methodology

The study involved treating ICR mice with cambinol and measuring Brucella CFUs in spleens and cytokine levels in serum.

Limitations

The study was limited to a specific mouse model and may not fully represent human responses.

Participant Demographics

Eight-week-old female ICR mice were used in the study.

Statistical Information

P-Value

0.0575

Statistical Significance

p=0.0575

Digital Object Identifier (DOI)

10.3390/microorganisms12122533

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication